14619408

Source:http://linkedlifedata.com/resource/pubmed/id/14619408

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
pubmed:issue	7
pubmed:dateCreated	2003-11-17
pubmed:abstractText	Nemifitide is a peptide under development by Innapharma for the potential treatment of depression. By June 2001, the first phase II trial of nemifitide in moderate to severely depressed individuals had been completed and in February 2003, Innapharma anticipated that phase III trials would commence later that year.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100965718
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Drugs, Investigational, http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides, http://linkedlifedata.com/resource/pubmed/chemical/nemifitide ditriflutate
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1472-4472
pubmed:author	pubmed-author:DingemanseJasperJ
pubmed:issnType	Print
pubmed:volume	4
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	859-62
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:14619408-Animals, pubmed-meshheading:14619408-Clinical Trials as Topic, pubmed-meshheading:14619408-Depressive Disorder, Major, pubmed-meshheading:14619408-Drugs, Investigational, pubmed-meshheading:14619408-Humans, pubmed-meshheading:14619408-Oligopeptides, pubmed-meshheading:14619408-Technology, Pharmaceutical
pubmed:year	2003
pubmed:articleTitle	Nemifitide. Innapharma.
pubmed:affiliation	Department of Clinical Pharmacology, Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, 4123 Allschwil, Switzerland. Jasper.Dingemanse@actelion.com
pubmed:publicationType	Journal Article, Review